PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

NCT00240162 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
OTHER
Sponsor class

Stopped investigator letter from drug manufacturer stating animal studies showed increased risk of cancer which was an unknown adverse event

Conditions

Interventions

Sponsor

Washington University School of Medicine